LRSN.F Stock Overview
Operates in the cannabis industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Global Health Clinics Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0011 |
| 52 Week High | CA$0.0011 |
| 52 Week Low | CA$0.0011 |
| Beta | 2.38 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -99.50% |
| 5 Year Change | -99.97% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| LRSN.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 4.1% | 2.0% |
| 1Y | n/a | 4.6% | 32.4% |
Return vs Industry: Insufficient data to determine how LRSN.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how LRSN.F performed against the US Market.
Price Volatility
| LRSN.F volatility | |
|---|---|
| LRSN.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LRSN.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LRSN.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Jay Dhaliwal | globalhealthltd.ca |
Global Health Clinics Ltd. operates in the cannabis industry. The company operates medical clinics, which guide patients through the process of becoming legal users of marijuana. It develops psilocybin products for research and usage for pharmaceutical purposes.
Global Health Clinics Ltd. Fundamentals Summary
| LRSN.F fundamental statistics | |
|---|---|
| Market cap | US$169.76k |
| Earnings (TTM) | -US$755.80k |
| Revenue (TTM) | US$62.44k |
2.7x
P/S Ratio-0.2x
P/E RatioIs LRSN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LRSN.F income statement (TTM) | |
|---|---|
| Revenue | CA$86.36k |
| Cost of Revenue | CA$20.76k |
| Gross Profit | CA$65.60k |
| Other Expenses | CA$1.11m |
| Earnings | -CA$1.05m |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 75.96% |
| Net Profit Margin | -1,210.42% |
| Debt/Equity Ratio | -45.4% |
How did LRSN.F perform over the long term?
See historical performance and comparison